• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基质雄激素受体缺失通过调节促炎细胞因子/趋化因子抑制前列腺肿瘤发生。

Loss of stromal androgen receptor leads to suppressed prostate tumourigenesis via modulation of pro-inflammatory cytokines/chemokines.

机构信息

Departments of Pathology, Urology, and Radiation Oncology, University of Rochester Medical Center, Rochester, NY, USA.

出版信息

EMBO Mol Med. 2012 Aug;4(8):791-807. doi: 10.1002/emmm.201101140. Epub 2012 Jun 29.

DOI:10.1002/emmm.201101140
PMID:22745041
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3494077/
Abstract

Stromal-epithelial interaction is crucial to mediate normal prostate and prostate cancer (PCa) development. The indispensable roles of mesenchymal/stromal androgen receptor (AR) for the prostate organogenesis have been demonstrated by using tissue recombination from wild-type and testicular feminized mice. However, the stromal AR functions in the tumour microenvironment and the underlying mechanisms governing the interactions between the epithelium and stroma are not completely understood. Here, we have established the first animal model with AR deletion in stromal fibromuscular cells (dARKO, AR knockout in fibroblasts and smooth muscle cells) in the Pten(+/-) mouse model that can spontaneously develop prostatic intraepithelial neoplasia (PIN). We found that loss of stromal fibromuscular AR led to suppression of PIN lesion development with alleviation of epithelium proliferation and tumour-promoting microenvironments, including extracellular matrix (ECM) remodelling, immune cell infiltration and neovasculature formation due, in part, to the modulation of pro-inflammatory cytokines/chemokines. Finally, targeting stromal fibromuscular AR with the AR degradation enhancer, ASC-J9®, resulted in the reduction of PIN development/progression, which might provide a new approach to suppress PIN development.

摘要

间质-上皮相互作用对于调节正常前列腺和前列腺癌(PCa)的发展至关重要。通过使用来自野生型和睾丸女性化小鼠的组织重组,已经证明了间质/基质雄激素受体(AR)对前列腺发生的不可或缺作用。然而,肿瘤微环境中的基质 AR 功能以及支配上皮和基质之间相互作用的潜在机制尚不完全清楚。在这里,我们在 Pten(+/-)小鼠模型中建立了第一个间质纤维肌肉细胞中 AR 缺失(dARKO,成纤维细胞和平滑肌细胞中的 AR 敲除)的动物模型,该模型可以自发发展前列腺上皮内瘤(PIN)。我们发现,间质纤维肌肉 AR 的缺失导致 PIN 病变发展受到抑制,上皮增殖和促进肿瘤的微环境得到缓解,包括细胞外基质(ECM)重塑、免疫细胞浸润和新血管形成,部分原因是促炎细胞因子/趋化因子的调节。最后,用 AR 降解增强剂 ASC-J9®靶向间质纤维肌肉 AR,导致 PIN 发展/进展减少,这可能为抑制 PIN 发展提供一种新方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8035/3494077/5339301756c5/emmm0004-0791-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8035/3494077/1ad2ec5085bb/emmm0004-0791-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8035/3494077/fa892f1f024b/emmm0004-0791-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8035/3494077/23983fc17ad4/emmm0004-0791-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8035/3494077/92417539b5aa/emmm0004-0791-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8035/3494077/65f5ed146d01/emmm0004-0791-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8035/3494077/3ce7dc3cf329/emmm0004-0791-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8035/3494077/a694fa255505/emmm0004-0791-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8035/3494077/5339301756c5/emmm0004-0791-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8035/3494077/1ad2ec5085bb/emmm0004-0791-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8035/3494077/fa892f1f024b/emmm0004-0791-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8035/3494077/23983fc17ad4/emmm0004-0791-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8035/3494077/92417539b5aa/emmm0004-0791-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8035/3494077/65f5ed146d01/emmm0004-0791-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8035/3494077/3ce7dc3cf329/emmm0004-0791-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8035/3494077/a694fa255505/emmm0004-0791-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8035/3494077/5339301756c5/emmm0004-0791-f8.jpg

相似文献

1
Loss of stromal androgen receptor leads to suppressed prostate tumourigenesis via modulation of pro-inflammatory cytokines/chemokines.基质雄激素受体缺失通过调节促炎细胞因子/趋化因子抑制前列腺肿瘤发生。
EMBO Mol Med. 2012 Aug;4(8):791-807. doi: 10.1002/emmm.201101140. Epub 2012 Jun 29.
2
Infiltrating macrophages promote prostate tumorigenesis via modulating androgen receptor-mediated CCL4-STAT3 signaling.浸润性巨噬细胞通过调节雄激素受体介导的 CCL4-STAT3 信号促进前列腺肿瘤发生。
Cancer Res. 2013 Sep 15;73(18):5633-46. doi: 10.1158/0008-5472.CAN-12-3228. Epub 2013 Jul 22.
3
New therapeutic approach to suppress castration-resistant prostate cancer using ASC-J9 via targeting androgen receptor in selective prostate cells.采用 ASC-J9 通过靶向选择性前列腺细胞中的雄激素受体抑制去势抵抗性前列腺癌的新治疗方法。
Am J Pathol. 2013 Feb;182(2):460-73. doi: 10.1016/j.ajpath.2012.10.029. Epub 2012 Dec 4.
4
Targeting stromal androgen receptor suppresses prolactin-driven benign prostatic hyperplasia (BPH).靶向基质雄激素受体可抑制催乳素驱动的良性前列腺增生(BPH)。
Mol Endocrinol. 2013 Oct;27(10):1617-31. doi: 10.1210/me.2013-1207. Epub 2013 Jul 26.
5
Suppressed prostate epithelial development with impaired branching morphogenesis in mice lacking stromal fibromuscular androgen receptor.在缺乏基质纤维肌性雄激素受体的小鼠中,前列腺上皮发育受抑制,分支形态发生受损。
Mol Endocrinol. 2012 Jan;26(1):52-66. doi: 10.1210/me.2011-1189. Epub 2011 Dec 1.
6
Targeting the stromal androgen receptor in primary prostate tumors at earlier stages.在早期原发性前列腺肿瘤中靶向基质雄激素受体。
Proc Natl Acad Sci U S A. 2008 Aug 26;105(34):12188-93. doi: 10.1073/pnas.0804701105. Epub 2008 Aug 22.
7
p300 acetyltransferase regulates androgen receptor degradation and PTEN-deficient prostate tumorigenesis.p300 乙酰转移酶调节雄激素受体降解和 PTEN 缺失型前列腺肿瘤发生。
Cancer Res. 2014 Mar 15;74(6):1870-1880. doi: 10.1158/0008-5472.CAN-13-2485. Epub 2014 Jan 30.
8
Stromal androgen receptor roles in the development of normal prostate, benign prostate hyperplasia, and prostate cancer.基质雄激素受体在正常前列腺、良性前列腺增生和前列腺癌发展中的作用。
Am J Pathol. 2015 Feb;185(2):293-301. doi: 10.1016/j.ajpath.2014.10.012. Epub 2014 Nov 26.
9
Androgen receptor (AR) degradation enhancer ASC-J9 in an FDA-approved formulated solution suppresses castration resistant prostate cancer cell growth.雄激素受体 (AR) 降解增强剂 ASC-J9 在一种获得 FDA 批准的配方溶液中抑制去势抵抗性前列腺癌细胞生长。
Cancer Lett. 2018 Mar 28;417:182-191. doi: 10.1016/j.canlet.2017.11.038. Epub 2018 Jan 17.
10
Transforming growth factor beta 1 and androgen receptors in prostate neoplasia.转化生长因子β1与前列腺肿瘤中的雄激素受体
Anal Quant Cytol Histol. 2000 Oct;22(5):403-10.

引用本文的文献

1
Tracing the Evolution of Sex Hormones and Receptor-Mediated Immune Microenvironmental Differences in Prostate and Bladder Cancers: From Embryonic Development to Disease.追踪前列腺癌和膀胱癌中性激素的演变以及受体介导的免疫微环境差异:从胚胎发育到疾病
Adv Sci (Weinh). 2025 Apr;12(13):e2407715. doi: 10.1002/advs.202407715. Epub 2025 Feb 25.
2
Deciphering the Tumor Microenvironment in Prostate Cancer: A Focus on the Stromal Component.解析前列腺癌中的肿瘤微环境:聚焦于基质成分。
Cancers (Basel). 2024 Oct 31;16(21):3685. doi: 10.3390/cancers16213685.
3
Interactions between androgen and IGF1 axes in prostate tumorigenesis.

本文引用的文献

1
Suppressed prostate epithelial development with impaired branching morphogenesis in mice lacking stromal fibromuscular androgen receptor.在缺乏基质纤维肌性雄激素受体的小鼠中,前列腺上皮发育受抑制,分支形态发生受损。
Mol Endocrinol. 2012 Jan;26(1):52-66. doi: 10.1210/me.2011-1189. Epub 2011 Dec 1.
2
CCAAT/enhancer-binding protein β and NF-κB mediate high level expression of chemokine genes CCL3 and CCL4 by human chondrocytes in response to IL-1β.CCAAT/增强子结合蛋白 β 和 NF-κB 介导人软骨细胞对 IL-1β 反应中趋化因子基因 CCL3 和 CCL4 的高水平表达。
J Biol Chem. 2010 Oct 22;285(43):33092-33103. doi: 10.1074/jbc.M110.130377. Epub 2010 Aug 11.
3
雄激素与胰岛素样生长因子1(IGF1)轴在前列腺肿瘤发生过程中的相互作用。
Nat Rev Urol. 2025 May;22(5):268-275. doi: 10.1038/s41585-024-00942-3. Epub 2024 Oct 7.
4
Stromal androgen signaling governs essential niches in supporting prostate development and tumorigenesis.基质雄激素信号调控支持前列腺发育和肿瘤发生的关键小生境。
Oncogene. 2024 Nov;43(47):3419-3425. doi: 10.1038/s41388-024-03175-1. Epub 2024 Oct 5.
5
Multiplex imaging of localized prostate tumors reveals altered spatial organization of AR-positive cells in the microenvironment.局限性前列腺肿瘤的多重成像显示微环境中雄激素受体(AR)阳性细胞的空间组织发生改变。
iScience. 2024 Aug 3;27(9):110668. doi: 10.1016/j.isci.2024.110668. eCollection 2024 Sep 20.
6
Stressed target cancer cells drive nongenetic reprogramming of CAR T cells and solid tumor microenvironment.应激靶癌细胞驱动 CAR T 细胞和实体瘤微环境的非遗传重编程。
Nat Commun. 2023 Sep 15;14(1):5727. doi: 10.1038/s41467-023-41282-x.
7
Cellular specificity of androgen receptor, coregulators, and pioneer factors in prostate cancer.雄激素受体、共调节因子和先驱因子在前列腺癌中的细胞特异性
Endocr Oncol. 2022 Sep 8;2(1):R112-R131. doi: 10.1530/EO-22-0065. eCollection 2022 Jan.
8
Cancer Cell-Extrinsic Roles for the Androgen Receptor in Prostate Cancer.雄激素受体在前列腺癌中的肿瘤细胞外作用。
Endocrinology. 2023 Apr 17;164(6). doi: 10.1210/endocr/bqad078.
9
Stressed target cancer cells drive nongenetic reprogramming of CAR T cells and tumor microenvironment, overcoming multiple obstacles of CAR T therapy for solid tumors.应激的靶癌细胞驱动CAR-T细胞和肿瘤微环境的非基因重编程,克服了CAR-T细胞疗法治疗实体瘤的多个障碍。
Res Sq. 2023 Feb 21:rs.3.rs-2595410. doi: 10.21203/rs.3.rs-2595410/v1.
10
Androgen Receptor Signaling Inhibition in Advanced Castration Resistance Prostate Cancer: What Is Expected for the Near Future?晚期去势抵抗性前列腺癌中的雄激素受体信号传导抑制:近期前景如何?
Cancers (Basel). 2022 Dec 9;14(24):6071. doi: 10.3390/cancers14246071.
Androgen receptor promotes hepatitis B virus-induced hepatocarcinogenesis through modulation of hepatitis B virus RNA transcription.
雄激素受体通过调节乙型肝炎病毒 RNA 转录促进乙型肝炎病毒诱导的肝癌发生。
Sci Transl Med. 2010 May 19;2(32):32ra35. doi: 10.1126/scitranslmed.3001143.
4
Differential androgen receptor signals in different cells explain why androgen-deprivation therapy of prostate cancer fails.不同细胞中的雄激素受体信号差异解释了为何前列腺癌的去雄激素治疗会失败。
Oncogene. 2010 Jun 24;29(25):3593-604. doi: 10.1038/onc.2010.121. Epub 2010 May 3.
5
Immunity, inflammation, and cancer.免疫、炎症与癌症。
Cell. 2010 Mar 19;140(6):883-99. doi: 10.1016/j.cell.2010.01.025.
6
B-cell-derived lymphotoxin promotes castration-resistant prostate cancer.B 细胞来源的淋巴毒素促进去势抵抗性前列腺癌。
Nature. 2010 Mar 11;464(7286):302-5. doi: 10.1038/nature08782.
7
Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-kappaB-Dependent Manner.癌相关成纤维细胞在早期肿瘤发生时被激活,以 NF-κB 依赖的方式协调促进肿瘤的炎症反应。
Cancer Cell. 2010 Feb 17;17(2):135-47. doi: 10.1016/j.ccr.2009.12.041. Epub 2010 Feb 4.
8
Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice.靶向成纤维细胞激活蛋白抑制小鼠肿瘤基质生成和生长。
J Clin Invest. 2009 Dec;119(12):3613-25. doi: 10.1172/JCI38988. Epub 2009 Nov 16.
9
Monocyte/macrophage androgen receptor suppresses cutaneous wound healing in mice by enhancing local TNF-alpha expression.单核细胞/巨噬细胞雄激素受体通过增强局部 TNF-α 的表达抑制小鼠皮肤伤口愈合。
J Clin Invest. 2009 Dec;119(12):3739-51. doi: 10.1172/JCI39335. Epub 2009 Nov 9.
10
Pten in stromal fibroblasts suppresses mammary epithelial tumours.基质成纤维细胞中的Pten抑制乳腺上皮肿瘤。
Nature. 2009 Oct 22;461(7267):1084-91. doi: 10.1038/nature08486.